Wells Fargo’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$141K Buy
64,894
+1,379
+2% +$3.01K ﹤0.01% 4582
2025
Q1
$173K Buy
63,515
+2,104
+3% +$5.74K ﹤0.01% 4362
2024
Q4
$255K Buy
61,411
+13,376
+28% +$55.6K ﹤0.01% 4165
2024
Q3
$187K Buy
48,035
+2,064
+4% +$8.03K ﹤0.01% 4243
2024
Q2
$180K Buy
45,971
+15,285
+50% +$59.9K ﹤0.01% 4223
2024
Q1
$129K Buy
30,686
+3,933
+15% +$16.5K ﹤0.01% 4379
2023
Q4
$126K Buy
26,753
+5,312
+25% +$25K ﹤0.01% 4367
2023
Q3
$66.9K Sell
21,441
-12,117
-36% -$37.8K ﹤0.01% 4681
2023
Q2
$154K Buy
33,558
+17,858
+114% +$82K ﹤0.01% 4493
2023
Q1
$77.7K Buy
15,700
+15,686
+112,043% +$77.6K ﹤0.01% 4660
2022
Q4
$76 Sell
14
-225
-94% -$1.22K ﹤0.01% 6536
2022
Q3
$2K Sell
239
-285
-54% -$2.39K ﹤0.01% 5834
2022
Q2
$2K Sell
524
-91,541
-99% -$349K ﹤0.01% 6048
2022
Q1
$644K Sell
92,065
-6,034
-6% -$42.2K ﹤0.01% 3971
2021
Q4
$1M Sell
98,099
-89,556
-48% -$913K ﹤0.01% 3847
2021
Q3
$2.29M Buy
+187,655
New +$2.29M ﹤0.01% 3368